COVID- Associated Immune Thrombocytopenia (COVID-ITP) in Pandemic
Full text article
References
Cooper N, Ghanima W, Immune Thrombocytopenia. N. Engl J Med. 2019; 381:945-55.
Pavord S, Scully M, Hunt BJ, Lester W, Bagot C, Craven B, Rampotas A, Ambler G, Makris M. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis. N Engl J Med. 2021 Oct 28;385(18):1680-1689. doi: 10.1056/NEJMoa2109908. Epub 2021 Aug 11. PMID: 34379914.
Immune Thrombocytopenia Secondary to COVID-19: a Systemic Review. SN Comprehensive Clinical Medicine; Springer Nature Journal. Sept,2020. https://doi.org/10.1007/s42399-020-00521-8
Towards understanding ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). Greinacher,Selleng,Wesche,Hdtke et al, preprint.https://www.researchsquare.com/article/rs-440461/v1(Accessed on April 27,2021).
GreinacherA,Selleng K,Mayerle J, et al. Anti-SARS-CoV-2 spike protein and anti-platelet factor 4 antibody responses induced by COVID-19 disease and ChAdOx1 nCov-19 vaccination. April 09,2021.
Lee EJ, Cines DB, Gernsheimer T, et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 2021; 96:534-7.
ASH-Expert opinion: Thrombosis with thrombocytopenia syndrome. Version 1:4; updated April 29,2021.
Authors
Copyright (c) 2021 Mohiuddin Ahmed Khan
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open access article published under the Creative Commons Attribution 4.0 International License, which permits its free use, distribution, and reproduction in any medium or format, even used for commercial purposes, provided the original work is properly cited.